Lukert B P, Adams J S
Arch Intern Med. 1976 Nov;136(11):1249-53.
Serum calcium and phosphorus levels, urinary excretion rates of calcium, phosphorus, and cyclic adenosine monophosphate (cAMP), and plasma parathyroid hormone (PTH) concentrations were determined in 11 normal subjects and in nine patients maintained on long-term prednisone therapy for chronic obstructive pulmonary disease. These same determinations were repeated in five of the prednisone-treated patients during the course of a seven-day calcium infusion. Prior to the infusion, the prednisone-treated patients demonstrated significantly elevated serum levels of PTH (P less than .005) and increased rates of urinary phosphate and cAMP excreation (P less than .005) when compared with normal subjects. After initiation of calcium infusion, the previous elevations in all of these determinations decreased to near normal levels. These data suggest that the effects of secondary hyperparathyroidism in patients maintained on long-term prednisone therapy may be overcome when calcium is administered intravenously.
对11名正常受试者以及9名因慢性阻塞性肺疾病接受长期泼尼松治疗的患者,测定了血清钙和磷水平、钙、磷及环磷酸腺苷(cAMP)的尿排泄率以及血浆甲状旁腺激素(PTH)浓度。在7天的钙剂输注过程中,对5名接受泼尼松治疗的患者重复进行了上述相同测定。输注前,与正常受试者相比,接受泼尼松治疗的患者血清PTH水平显著升高(P<0.005),尿磷酸盐和cAMP排泄率增加(P<0.005)。开始钙剂输注后,所有这些测定指标先前的升高均降至接近正常水平。这些数据表明,静脉补钙时可克服长期接受泼尼松治疗患者继发性甲状旁腺功能亢进的影响。